###begin article-title 0
Hematopoietic progenitor cells and interleukin-stimulated endothelium: expansion and differentiation of myeloid precursors
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Cytokine-stimulated endothelial cells (EC) propagate hematopoietic progenitor cell (HPC) expansion. However, the effects on the functional capacities of cultured progenitors have not been evaluated. HPC were assessed by flow cytometry, colony and cobblestone assays and long-term cultures (LTC) after culturing in the supernatant of EC stimulated by IL-1beta, IL-3 or IL-6.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
EC incubation with IL-6 did not improve cell expansion in comparison to non-stimulated EC supernatant, while the HPCs' phenotype and functional capacities were retained. In contrast, IL-1beta and IL-3 stimulation resulted in a 10- and 100-fold increase in cell numbers with more than 90% of these cells being CD33(+). Plating efficiencies and LTC initiating cells were greatest in IL-6 supernatants, whereas the highest numbers of burst-forming units were observed using IL-3. IL-1beta supernatants diminished the number of 5-week cobblestone-areas, whereas the number of 2-week cobblestone areas remained equal to freshly isolated HPC. Fewer 2-week cobblestones and greater amounts of 5-week cobblestones were observed with IL-6 and IL-3. Expanded progenitors from all interleukin conditions were further matured into functional granulocytes.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
IL-1beta and IL-3 stimulated endothelium induces proliferation and differentiation of myeloid precursors, while IL-6 treatment induced a benefit of HPC survival.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 269 270 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
During local inflammation, a cytokinetic firework initiated by cellular defense mechanisms includes the secretion of TNFalpha, interleukin-1, -3 and -6. These cytokines promote the release of endothelial factors which also attract hematopoietic progenitor cells (HPC) [1]. Therefore, the use of cytokine-stimulated endothelium as a hematopoietic feeder layer could be of great interest.
###end p 9
###begin p 10
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 460 461 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 567 568 564 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 666 667 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 807 808 804 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 960 961 957 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 988 989 985 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1120 1122 1117 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1172 1174 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1266 1268 1263 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1316 1318 1313 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1351 1353 1348 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 652 657 <span type="species:ncbi:9606">human</span>
Several cellular immune reactions are triggered by interleukins (IL) with multiple impacts on lymphocytes, granulocytes and endothelial cells [2]. IL-1, for example, induces prostaglandin E2 and collagenase synthesis thereby activating the metabolism of polymorphnuclear neutrophils [3]. The secretion of endothelial granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) is further stimulated by IL-1beta [4]. IL-3 in synergism with GM-CSF, on the other hand, controls the HPC differentiation into myeloid cells [5]. In synergism with IL-6, IL-3 also supports the proliferation of progenitors from human blasts [6]. Within the bone marrow niche, IL-6, which is also produced by vasulcar endothelial cells, propagates the differentiation of neutrophils [7]. Both, IL-6 and a recombinant form of its soluble receptor, the so-called hyper IL-6, enhance the SCF-induced expansion of hematopoietic progenitors [8] through gp130 signaling [9]. IL-6, a mediator of the acute phase response, is one of the most complex cytokines released at sites of injuries or infections [10], and many of its activities are shared by IL-1 [11]. On endothelial cells, IL-6 preferentially supports endothelial adherence of lymphocytes [10] and induces endothelial cells to proliferate [12] hereby enhancing angiogenesis [13].
###end p 10
###begin p 11
###xml 318 320 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
Taken together, these three inflammatory stimuli induce the secretion of endothelial factors propagating the proliferation and differentiation of HPC. We previously demonstrated that endothelial cells (EC) stimulated by tumor necrosis factor alpha (TNFalpha) induce the generation of dendritic cells from CD34(+) HPC [14]. Here, we present data contributing to the influence of the supernatants from interleukin-stimulated endothelium on the proliferation and differentiation of HPC into granulocytes which highlights potential use of endothelial cells for the maintenance and maturation of blood cells.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Cell expansion
###end title 13
###begin p 14
###xml 169 170 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 295 297 292 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 312 313 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 333 335 327 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 350 351 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 424 426 418 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 447 448 438 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Direct contact between IL-beta or IL3 stimulated EC and HPC significantly reduced the cumulative cell output as compared to non-contact and supernatant cultures (Figure 1). Stimulated supernatants led to two to three times higher cumulative cell counts than non-contact cultures (IL-3: 14.1 x 106 versus 8.5 x 106; IL-1beta: 9.3 x 106 versus 3.7 x 106), which were twice as high as in direct contact cultures (IL-3: 3.6 x 106 and IL-1beta:1.9 x 106). Differences between IL-1beta and IL-3 in cumulative cell numbers were not significant (p = 0.12). In IL-6 conditions, direct contact and supernatant conditions led to comparable cumulative cell counts (p > 0.13). Cell numbers in non-stimulated EC supernatant, to which single interleukins were added, had significantly lower cell counts in IL-1beta and IL-3 conditions and lower cell numbers in IL-6 conditions, which was also the case, when HPC were cultured in endothelial plus stem cell medium including interleukins. IL-3 stimulated bone marrow fibroblasts led to significantly lower cumulative cell counts inducing on average a 15-fold cell expansion after two weeks. No significant differences were seen among different interleukins.
###end p 14
###begin p 15
###xml 0 107 0 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cumulative cell counts of proliferating progenitors in direct contact, non-contact and supernatant cultures</bold>
###xml 304 316 301 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open squares</italic>
###xml 410 422 403 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circles</italic>
###xml 484 498 474 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">closed circles</italic>
###xml 693 707 682 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">closed circles</italic>
###xml 1068 1070 1043 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 1226 1240 1201 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open triangles</italic>
###xml 1261 1268 1236 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crosses</italic>
###xml 1296 1312 1271 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">closed triangles</italic>
Cumulative cell counts of proliferating progenitors in direct contact, non-contact and supernatant cultures. Cell counts were determined by demi-depopulation after 7, 14 and 21 days and summarized. Culture conditions were as follows: A) HPC in direct contact with IL1-beta stimulated EC (Direct Contact, open squares), on a 0.4 mum microporous transmembrane above the IL-1beta stimulated EC (Indirect Contact, open circles), in the supernatant of IL-1beta stimulated EC (Supernatant, closed circles), B) in direct contact with IL-3 stimulated EC (Direct Contact), on a 0.4 mum microporous transmembrane above IL-3 stimulated EC (Indirect Contact) and in the supernatant of IL-3 stimulated EC (closed circles). Significant differences to contact cultures (*), to indirect contact cultures (#) and to bone marrow (section sign were only found in IL-1beta and IL-3 dependent conditions. C) No significant differences were determined among the IL-6 stimulated EC culture conditions or among bone marrow fibroblast cultures. The HPC cell count at the beginning was 5.5 x 104 per 3 ml. Each point represents the average of at least three independent measurements. Bone marrow (BM) fibroblast cocultures consisted of direct contact (open triangles), indirect contact (crosses) and supernatant cultures (closed triangles). Dotted lines: HPC cultured in endothelial supernatants, to which IL-1beta, IL-3 or IL-6 was added.
###end p 15
###begin p 16
###xml 336 337 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 465 471 <span type="species:ncbi:9913">bovine</span>
Since the highest cumulative cell numbers were achieved by culturing the HPC in stimulated endothelial supernatants, all further studies were preformed using these. Following a 7-days culture period, a minimum of 10-fold cell proliferation was observed in the supernatant of IL-1beta and IL-3 stimulated endothelial supernatants (Table 1). After 14 days in culture, cell counts increased more than 140x with IL-1beta, 83x with IL-3, and 6x in non-stimulated and in bovine serum albumin (BSA)-stimulated endothelial supernatants. Administration of IL-6 resulted in a five-fold increase in the cell number following two weeks in culture, which was equal to the fold increase of BSA- and non-stimulated endothelial supernatants (p > 0.13).
###end p 16
###begin p 17
Cell expansion in IL-stimulated endothelial supernatant following a period of 7 and 14 days and flow cytometric profile on day 7.
###end p 17
###begin p 18
Fold expansions were determined following a period of seven and fourteen days. Percentage of CD33, 34, 45, 14, 16 and CD133 positivity are depicted as circles (o: negative, less than 10%; quarter circle: 10 - 25% positivity; half circle: 25 - 50% positivity; ‚óè more than 75% positive cells).
###end p 18
###begin p 19
a: highly significant different compared to non-stimulated supernatant (p < 0.001); b: highly significant different compared to BSA supernatant (p < 0.001). Shown are mean results +/- SE of twelve independent experiments. N/A: not applicable.
###end p 19
###begin p 20
Optimum concentrations for IL-1beta induced cell expansion were 100 and 1.000 U/ml, while IL-3 was observed to induce the highest cell numbers at 100 U/ml, though differences were not significant among different concentrations. Time-course observations demonstrated that IL-stimulation at varying concentrations (10, 100 and 1,000 U/ml) for 16 hours provided the highest increase in cell numbers as compared to 2, 4, 8, 24 and 48 hours.
###end p 20
###begin title 21
Characteristics of expanded cells
###end title 21
###begin p 22
###xml 338 339 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 693 694 686 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 875 876 865 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
More than 93% of the freshly isolated cells were positive for CD34, CD33 and CD45. The latter two remained highly positive following a period of two weeks in all of the culture conditions analyzed. When cultured with IL-1beta or IL-3-stimulated supernatant, expanded cells lost the CD34 antigen following a one week culture period (Table 1). In contrast, on average 34.8 +/- 6.7% of the cells cultured in BSA, IL-6 or non-stimulated supernatant stained positive for CD133, and 17.7 +/- 5.2% were still CD34 positive in IL-6 induced supernatant. Although the loss of CD34 antigen was paralleled by a loss of CD133, a subset of CD34(-) cells retained the CD133 glycoprotein (see additional file 1)). Following a two week culture period, half of the cells in the IL-1beta stimulated EC supernatant were CD16(+), and 15-25% of the cells carried the monocytic marker CD14 (Figure 2). Other glycoproteins tested were CD15 and CD19, which were rarely present in freshly isolated CD34 cells and did not increase upon culturing.
###end p 22
###begin p 23
###xml 0 136 0 136 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cytospin preparations of freshly isolated HPC and following culture for two weeks in non-stimulated, BSA or IL-stimulated EC supernatant</bold>
###xml 159 176 159 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(Post isolation) </italic>
Cytospin preparations of freshly isolated HPC and following culture for two weeks in non-stimulated, BSA or IL-stimulated EC supernatant. Freshly isolated HPC (Post isolation) with a dense nucleus and small cytoplasmatic rim increased up to two-fold in size and gained cytoplasma in non-stimulated and BSA-stimulated supernatants. With IL-1beta stimulated supernatant they developed into hypersegmented cells and also into monocytic cells in part, with an increase in cytoplasma content. More than 50% of the cells stimulated with IL-3 developed eosinophilic granula, whereas cells in IL-6 stimulated supernatant resembled freshly isolated cells. Cells cultured in IL-6, BSA- and non-stimulated supernatants were still positive for CD34 and CD133. Diffquik staining, size bar 1 mum. magnifications x200. One representative result of twelve independent experiments.
###end p 23
###begin p 24
###xml 249 250 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
The receptor repertoire matched the observed changes in morphology. IL-1beta and IL-3 generated supernatant induced a rather versatile morphology consisting of macrophage and granulocytic precursors with eosinophilic granula in case of IL-3 (Figure 2). In contrast, cells cultured in IL-6 stimulated EC mostly resembled freshly isolated HPC with round nuclei and low cytoplasmatic content. Cells expanded in non-stimulated or BSA supernatant increased slightly gaining little cytoplasm.
###end p 24
###begin title 25
Hematopoietic potential of expanded cells
###end title 25
###begin title 26
Colony formation
###end title 26
###begin p 27
###xml 225 226 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
A concentration-dependent increase of BFU-E colonies were determined in the cells cultured in supernatants from IL-1beta stimulated EC. BFU-E were significantly higher than in the non-stimulated supernatants (p < 0.05, Table 2), in freshly isolated HPC or in those expanded in BSA stimulated EC supernatants (p < 0.035 at IL1beta concentration of 1,000 U/ml). Here, the numbers of CFU-GM and mixed colonies were comparable to those observed post-isolation, but the plating efficiencies (PE) were the lowest being significantly lower than in freshly isolated HPC (p < 0.001).
###end p 27
###begin p 28
Colony forming activity of HPC expanded in IL-stimulated EC supernatant for one week.
###end p 28
###begin p 29
###xml 622 628 <span type="species:ncbi:9913">bovine</span>
Hematopoietic colony formation was determined after fourteen days in semisolid methylcellulose cultures supplemented with erythropoietin, GM-CSF, IL-3 and stem cell factor. Total colonies were defined by multiplying counted colonies with the number of expanded cells divided by the number of input cells. Mean values +/- SE from four to nine independent experiments conducted in triplicate. BFU-E: burst-forming unit erythrocyte; CFU-GM: colony-forming unit granulocyte macrophage; CFU-Mix; mixed colony-forming unit (granulocyte, erythrocyte, megakaryocyte, macrophage); PE: plating efficiency; N/A: not applicable; BSA: bovine serum albumin
###end p 29
###begin p 30
a: significant different compared to non-stimulated supernatant; b: significant different compared to BSA supernatant; c: significant different compared to freshly isolated CD34(+) cells.
###end p 30
###begin p 31
Significantly decreased plating efficiencies were also found in HPC expanded in IL-3 conditioned medium (p < 0.05). The values obtained were comparable to those in BSA-stimulated medium, but lower than those in naive EC supernatant at concentrations of 100 and 1.000 U/ml IL-3 (p < 0.02). With IL-3, the highest overall numbers of BFU-E and mixed colonies were determined with BFU-E numbers three to five times, and CFU-Mix numbers 15 - 40 times higher than in cells post-isolation (p </= 0.025).
###end p 31
###begin p 32
The highest plating efficiencies of all conditions tested were observed in cells cultured with IL-6 stimulated EC supernatant. At a concentration of 1,000 U/ml, plating efficiencies were two-fold higher than in cells cultured with non- or BSA-stimulated EC supernatant (p < 0.0026) and even significantly higher than in freshly isolated cells (p = 0.002). Compared to the latter group, the total numbers of BFU-E and CFU-GM were significantly lower at IL-6 concentrations of 10 U/ml (p = 0.005), but normalized at IL-6 concentrations of 100 U/ml and higher (p > 0.2).
###end p 32
###begin title 33
CAFC and LTC-IC
###end title 33
###begin p 34
###xml 429 430 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
The highest numbers of 2-week cobblestone area-forming cells were achieved following culture of HPC in IL-1beta stimulated supernatant. At a supraphysiological concentration of 10,000 U/ml, approximately four times more 2-week cobblestones were found than in cells post isolation and twice as many as in those cultured in BSA-stimulated supernatant (p < 0.05) indicating the expansion of predominately myeloid progenitors (Table 3). The number of 2-week CAFC were comparable to freshly isolated HPC (p > 0.36) and those grown in BSA-stimulated EC (p > 0.1) at all other IL-1beta concentrations. The highest numbers of 5-week CAFC, a parameter of the undifferentiated progenitors, were observed in cells which had been cultured in supernatants from IL6-, BSA- or non-stimulated EC. These CAFC figures were the only ones observed to be equivalent to those of freshly isolated HPC (IL-6: p > 0.095; BSA: p = 0.42; non-stimulated: p = 0.21). The highest numbers of LTC-IC were found in cells cultured in non-stimulated endothelial supernatant followed by freshly isolated CD34(+) cells and cells cultured in BSA- or IL-6 stimulated supernatants. Differences among these four groups were insignificant (p > 0.15). Significantly lower values were determined in cells expanded in 1,000 U/ml IL-1beta-stimulated EC (p < 0.037), and those expanded in IL-3-stimulated EC (p < 0.025).
###end p 34
###begin p 35
Cobblestone area and long-term culture initiating cells (LTC-IC) of HPC post-isolation and of cells cultured in IL-stimulated EC supernatant for one week.
###end p 35
###begin p 36
###xml 55 61 <span type="species:ncbi:10090">murine</span>
Freshly isolated and expanded HPC were cultured on the murine bone marrow stroma cell line MS-5 and scored for cobblestone-area formation after two and five weeks. LTC-IC were scored by replating 5-week CAFC in methylcellulose for secondary colony formation. Shown are mean results +/- SD of three independent experiments in triplicate; a: significant different compared to non-stimulated supernatant (p < 0.05); b: significant different compared to BSA supernatant (p < 0.05); c: significant different compared to freshly isolated CD34(+) cells.
###end p 36
###begin title 37
Granulocytic features and function of differentiated cells
###end title 37
###begin p 38
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 781 782 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
Extension of the cell culture for an additional week with G-CSF induced the up-regulation of the granulocytic markers CD16 and CD66 in all three interleukin conditions (Figure 3). Prior to G-CSF addition, only cells cultured in IL-1beta-stimulated endothelial supernatant already had a high frequency of CD16 and CD66 positive cells, which was further increased following the addition of G-CSF. Thereafter, the cells also became highly positive for CD15, CD11b and CD11c. Control granulocytes differentiated in stem cell medium plus cytokines in the absence of endothelial supernatant developed an equivalent morphology and immunephenotype. There were no differences between the burst activities of G-CSF matured granulocytes from different interleukin conditions (p > 0.05, Table 4).
###end p 38
###begin p 39
Burst activities of differentiated cells expanded in IL-stimulated endothelial supernatant.
###end p 39
###begin p 40
###xml 92 97 <span type="species:ncbi:9606">human</span>
###xml 178 185 <span type="species:ncbi:562">E. coli</span>
After culturing the cells for one week with G-CSF (100 ng/ml) and keeping them overnight in human serum, expanded cells showed a ten-fold increased burst activity in response to E. coli and PMA. Oxygen radical formation in cells from different interleukin conditions were comparable (p > 0.05). Shown are average results of mean fluorescence activities +/- SE from five independent experiments. In brackets: mean results after storage in FBS-based medium (n = 10).
###end p 40
###begin p 41
###xml 38 45 <span type="species:ncbi:562">E. coli</span>
###xml 47 63 <span type="species:ncbi:562">Escherichia coli</span>
PMA: phorbol 12-myristate 13-acetate; E. coli: Escherichia coli; fMLP: N-formyl-methionyl-leucyl-phenylalanin.
###end p 41
###begin p 42
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Flow cytometry of expanded cells before and after culturing for a subsequent week in G-CSF</bold>
Flow cytometry of expanded cells before and after culturing for a subsequent week in G-CSF. Expression of CD16 and CD66 was up-regulated in HPC expanded in IL-3 and IL-6 stimulated EC cultures (p < 0.05), while in IL-1beta cultures, no further up-regulation was observed. Increase of granulocytic glycoproteins occurred in parallel to the development of granulocytic morphology. Pictures were taken from one representative result of six independent experiments. A) forward scatter - side scatter, IgG control; B) CD16 and CD66 expression before culturing with G-CSF; C) CD16 and CD66 expression and cell morphology after culturing with G-CSF.
###end p 42
###begin p 43
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 591 593 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 924 926 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 468 473 <span type="species:ncbi:9606">human</span>
###xml 495 502 <span type="species:ncbi:562">E. coli</span>
###xml 658 663 <span type="species:ncbi:9606">human</span>
Differentiated cells were analyzed for their granulocytic function. Cells which were harvested directly from G-CSF cultures had high spontaneous burst rates, which were even higher than after they had been exposed to Escherichia (E.) coli (Figure 4A). Yet, these cells responded two- and ten-fold better to N-formyl-methionyl-leucyl-phenylalanin (fMLP) and phorbol 12-myristate 13-acetate (PMA), respectively. When the differentiated cells were incubated overnight in human serum at 37degreesC, E. coli or PMA induced a ten-fold burst, whereas no effect was seen in response to fMLP (Figure 4B). Burst rates between cells, which had been stored overnight in human serum and those without serum incubation were significantly different (p </= 0.018). Oxygen radical formation was also significantly higher in granulocytes generated in stimulated EC supernatant than in granulocytes differentiated with cytokines alone (Figure 4C), but lower than in granulocytes from peripheral blood.
###end p 43
###begin p 44
###xml 0 26 0 26 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Granulocytic functionality</bold>
###xml 86 93 <span type="species:ncbi:562">E. coli</span>
###xml 419 424 <span type="species:ncbi:9606">human</span>
###xml 741 748 <span type="species:ncbi:562">E. coli</span>
###xml 750 766 <span type="species:ncbi:562">Escherichia coli</span>
Granulocytic functionality. Phagoburst results are shown in response to PMA, fMLP and E. coli of HPC expanded in IL1-stimulated EC and following further differentiation by G-CSF in comparison to granulocytes differentiated by cytokines alone. A) HPC differentiated following expansion in IL1-stimulated EC supernatant; B) HPC differentiated following expansion in IL1-stimulated EC supernatant and overnight storage in human serum prior to analysis; C) HPC differentiated in a cytokine combination of erythropoietin, SCF and G-CSF without endothelial supernatant. Shown is one representative result of eight independent experiments. Shaded histograms: sample fluorescence; white line: negative control. PMA: phorbol 12-myristate 13-acetate; E. coli: Escherichia coli; fMLP: N-formyl-methionyl-leucyl-phenylalanin.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 23 33 <span type="species:ncbi:111938">gatekeeper</span>
Human endothelium, the gatekeeper between blood and tissue, plays a decisive role in the initiation of cellular immune responses [3]. The way in which endothelium influences HPC in the blood circulation during an inflammation, however, is unknown. The data presented here gives new insights into the unique role of endothelium as a conductor in the inflammatory orchestra, especially on the influence of IL-1beta, IL-3 and IL-6 stimulated endothelium on the proliferation and differentiation of HPC.
###end p 46
###begin p 47
###xml 178 180 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 205 207 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 218 220 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 233 235 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 486 488 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
The highest fold increases were determined in supernatants from IL-1beta-stimulated EC. IL-1, for example, does induce endothelial cells to secrete hematopoietic growth factors [15] like stem cell factor [16], GM-CSF [17] and G-CSF [18]. The latter two are well-known to be responsible for HPC expansion and granulocytic differentiation. In fact, Bioplex assays confirmed the IL-1beta induced increase of G-CSF, GM-CSF, IL-1, IL-6 and IL-8 which are known hematopoietic growth factors [19]. IL-13, IL-17, macrophage inflammatory protein 1 and monocyte chemoattractant protein 1 were also higher in IL-1beta stimulated EC supernatant than in BSA-stimulated samples. This could explain why predominately white blood cell precursors expanded in IL1beta-conditioned EC medium retaining CD33, a marker for myeloid progenitors. Functional tests proved the proliferation of myeloid progenitors resulting in high numbers of 2-wk cobblestones and the lack of primitive HPCs demonstrated by the absence of 5-wk CAFC and LTC-IC.
###end p 47
###begin p 48
###xml 89 90 86 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 264 266 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 668 677 662 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 714 716 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 811 813 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
One effect of IL-1beta on HPCs is the indirect enhancement of their sensitivity for IL3 [6], possibly by upregulating IL-3 receptors on endothelial cells. IL-3 improves the ex vivo expansion of HPC induced by FLT3/FLK2-ligand, stem cell factor and thrombopoietin [20]. In our culture system, IL-3 led to an equivalent fold increase of cell numbers as IL-1beta and the highest number of mixed colonies, which speaks in favor of the expansion of oligopotential HPC. The reduced number of 5-week cobblestones and long-term culture initiating cells, however, opposes the expansion of primitive hematopoietic stem cells. Administered on endothelial cells, IL-3 induces the in vitro adhesion of basophilic granulocytes [21] with endothelium supporting the IL-3 dependent differentiation of eosinophilic granulocytes [22]. The latter stands in agreement with our morphologic results showing the development of eosinophilic granula in expanded HPC.
###end p 48
###begin p 49
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 532 533 532 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 664 665 664 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
Another supporter of the IL-3 dependent HPC proliferation is IL-6 [23]. Previous works analyzed the importance of IL-6 within the hematopoietic/endothelial conundrum. For example, IL-6 was found to be one of the most crucial endothelial factors supporting HPC expansion in a combination of multiple cytokines plus endothelial cells [24]. More committed cells do express the receptor for IL-6 [25], whereas it is absent on early uncommitted HPC, although these cells are responsive to IL-6 in complex with the soluble IL-6 receptor [8,26]. Their combined use dramatically stimulates the expansion of primitive hematopoietic progenitor cells in the presence of SCF [8,26]. This might account for the observed delay in cell expansion, which led to a five-fold increase one week later than in IL-1beta and IL-3 endothelial supernatants.
###end p 49
###begin p 50
###xml 971 973 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1095 1100 <span type="species:ncbi:9606">human</span>
###xml 1101 1107 <span type="species:ncbi:9913">bovine</span>
In our study, HPC maintained in IL-6 stimulated EC supernatant retained CD34 and CD133, which was also the case in BSA- and non-stimulated cultures. Besides, cells grown in supernatants from IL-6, BSA or non-stimulated EC had the best plating efficiencies, the highest number of 5-week cobblestones and LTC-IC indicating that mainly primitive progenitors expanded. Considering the fold increases in BSA- and non-stimulated supernatant, one could hypothesize that IL-6 had no effect on the endothelial cells despite STAT3 phosphorylation. However, from the five conditions tested, only cells grown in IL-6-stimulated EC supernatant had a significantly higher plating efficiency than freshly isolated HPC. Therefore, IL-6 seemed to induce the secretion of endothelial factors propagating the expansion of hematopoietic progenitors, whereas IL-1beta and IL-3 induced the secretion of endothelial factors promoting the proliferation of myeloid precursors. In former studies [27], IL-6 could only affect endothelial chemokine production in the presence of soluble IL-6 receptor. As we used fetal and human bovine serum in our culture conditions, the soluble IL-6 receptor was probably drawn from the applied media supplements.
###end p 50
###begin p 51
###xml 856 858 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 859 861 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 862 864 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 985 987 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1249 1251 1246 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1018 1023 <span type="species:ncbi:9606">human</span>
###xml 1254 1259 <span type="species:ncbi:9606">Human</span>
The add-back of interleukins to non-stimulated EC conditioned medium did not significantly influence cell expansions compared to non-stimulated supernatant which speaks against a contaminating interleukin effect. Intriguingly, non-stimulated and BSA-generated supernatants also induced the proliferation of HPC, although at much lower levels. BSA stimulation actually increased endothelial G-CSF, GM-CSF, IL-6 and IL-8, though the levels were much lower than in IL-1beta stimulated supernatants (unpublished data). Following a period of two weeks, fold increases were equivalent to those determined in IL-6 conditioned medium, and the results of CAFC in combination with LTC-IC suggest that the expansion of undifferentiated HPC was initiated. This stands in line with other studies demonstrating that endothelial cells support HPC survival and expansion [14,28,29]. As co-infusion of bone marrow mesenchymal cells with bone marrow HPC supports engraftment of bone marrow transplants [30], simultaneous application of human umbilical cord EC with cord blood-derived HPC could improve the survival of cord blood grafts. Accordingly, cerebral endothelial cells were found to be very promising adjuvants for bone marrow regeneration in animal studies [31]. Human umbilical cords, a much more accessible source of endothelial cells, could be used in the same way, being isolated whenever cord blood is collected.
###end p 51
###begin p 52
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
In the absence of interleukins, more progenitors expanded, if they were cultured in direct contact with EC. When interleukins are added, however, a different scenario opens. Like Jazwiec and colleagues we found a higher cell expansion, if HPC and EC were cultured separately from each other [4]. This implies that ligand-receptor interactions between both cell types prevents HPC proliferation. Another reason could be that endothelial cells reabsorb hematopoietic growth factors in a paracrine-autocrine fashion [32], thereby competing with the HPC for growth factor internalization and consumption. Since endothelial cells are positive for c-kit, the receptor for stem cell factor, as well as GM- and G-CSF receptors [33,34], this could very well be the case.
###end p 52
###begin p 53
###xml 897 899 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 900 902 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 364 371 <span type="species:ncbi:562">E. coli</span>
###xml 519 524 <span type="species:ncbi:9606">human</span>
Expanded cells from all IL culture conditions could be differentiated into functionally mature granulocytes with typical granulocytic immunephenotypes and burst activities double as high as of HPC grown in cytokines alone. Although high reactions of cells generated in IL-stimulated medium were determined in response to PMA and fMLP, oxygen bursts in response to E. coli were initially below the negative control. This was related to high spontaneous burst rates, which disappeared, if the cells had been incubated in human serum overnight. That does imply that the culture medium contained fluorescent components which needed to be washed out before challenging the cells. One also has to bear in mind, that bacterial toxins and PMA are known as strong stimulators of ADAM17, a protease which is responsible for the shedding of various cell proteins like TNFalpha and the soluble IL-6 receptor [35,36]. Once transfused in vivo, these cells might therefore be functionally competent.
###end p 53
###begin p 54
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
In bioengineering, the use of feeder layers has been repeatedly recommended for HPC expansion [37-41]. Coculture models usually include the administration of stroma cells [42,43], while other groups focus on the application of endothelial cells [28,44,45].
###end p 54
###begin p 55
###xml 64 66 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 206 208 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 209 211 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 484 486 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 696 698 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 734 736 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 560 568 <span type="species:ncbi:9606">patients</span>
###xml 576 582 <span type="species:ncbi:10090">murine</span>
###xml 739 744 <span type="species:ncbi:9606">Human</span>
###xml 847 855 <span type="species:ncbi:9606">patients</span>
###xml 896 903 <span type="species:ncbi:9606">patient</span>
###xml 1025 1030 <span type="species:ncbi:9606">human</span>
In concordance with previous results on TNFalpha-stimulated EC [14], IL-stimulated bone marrow fibroblasts did not lead to the same fold increases as endothelium. In contrast to findings from other groups [46-48], IL-3 stimulated bone marrow fibroblasts led to significantly lower cumulative cell counts. One reason could be the fact that we used only single cytokines and not a combination of hematopoietic growth factors. Another could lie in the different sources of stroma cells [49]. We used either primary bone marrow stroma cells isolated from leukemic patients or the murine stroma cell line MS-5. The latter is known to support the expansion of primitive hematopoietic progenitor cells [50] in the absence of growth factors [51]. Human interleukins don't necessarily have to have a stimulatory effect on these. Stroma cells from leukemic patients are subjected to several variables like patient's age, stage of disease or therapeutic regime, which can account for an abnormal milieu in cell cultures. Though EC from human umbilical cords also vary interindividually, they still are of comparable quality.
###end p 55
###begin p 56
Since endothelial cells and cord blood HPC can be isolated from the same donor simultaneously, cytokine stimulated EC could be used in autologous bioreactors for the expansion and differentiation of homologous blood cells. This distinguishes endothelial cells as an attractive feeder population, permitting spatial separation of feeder and expanding cells. As supernatants of IL-stimulated EC led to higher fold increases as contact and indirect contact cultures, sequential instead of simultaneous culturing is possible starting with endothelial cell plating and harvesting of supernatants followed by HPC expansion cultures.
###end p 56
###begin p 57
###xml 134 141 134 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
In conclusion, supernatants from interleukin-stimulated endothelial cells can be used to expand and differentiate hematopoietic cells ex vivo. While IL-6 helped to preserve HPC functionality, IL-1beta and IL-3 rather induced the differentiation of granulocytic precursors. Further genetic analyses, e.g. by oligonucleotide microarrays of stimulated and non-stimulated EC could further clarify which factors involved in HPC expansion and/or differentiation are produced by endothelial cells.
###end p 57
###begin title 58
Methods
###end title 58
###begin title 59
Cord blood, HPC isolation
###end title 59
###begin p 60
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
Cord blood specimens were collected in heparin-coated syringes and blue caps from full-term delivered neonates, following written consents from the mothers. Mononuclear cell fractions were isolated by Ficol (Biochrom, Berlin, Germany) followed by two wash steps. CD34(+) HPC were immunomagnetically selected as previously described [52].
###end p 60
###begin title 61
IL-stimulation of endothelial and bone marrow stroma cells
###end title 61
###begin p 62
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1286 1289 1284 1287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5 </sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 274 280 <span type="species:ncbi:9913">bovine</span>
###xml 323 328 <span type="species:ncbi:9606">human</span>
###xml 572 580 <span type="species:ncbi:9606">patients</span>
###xml 729 735 <span type="species:ncbi:10090">murine</span>
Human umbilical cord EC were obtained by flushing umbilical veins with 0.1% collagenase (Sigma-Aldrich, Steinheim, Germany) [14]. The cells were then cultured in endothelial cell conditioning medium consisting of M199 (Biochrom, Berlin, Germany) supplemented with 16% fetal bovine serum (FBS, Hyclone, South Logan, UT), 4% human serum from healthy volunteers, 2 mM L-glutamine, 0.15 mg/ml endothelial growth factor supplement (Intracel; Rockville, MD), 0.015 mg/ml heparin and 1% fungicide. Bone marrow stroma cells were harvested from bone marrow aspirates from leukemia patients [14] and cultured in RPMI 1640 supplemented with 10% FBS, 2 mM L-glutamine and 100 U/ml penicillin/streptomycin. In two experiments, cells from the murine bone marrow line MS-5 (kindly provided by Katja Weisel, Germany) were used. Confluent monolayers from passages two to six were stimulated with either IL-1, -3 or -6 (all Peprotech, Rocky Hill, MD) for 16 hours. All cytokines were dissolved in 0.01% BSA and phosphate buffered saline (PBS). Supernatants were filtered through a 0.2 mum sterile filter and diluted 1:2 with stem cell medium. Stem cell medium consisted of Iscove's modified Dulbecco's medium (IMDM, Biochrom) supplemented with 20% FBS, 2 mM L-glutamine, 50 mug/ml gentamicin and 7.3 x 10-5 M mercaptoethanol. Optimum duration of interleukin-stimulation was evaluated in time-course experiments (2, 4, 8, 16, 24 and 48 hours).
###end p 62
###begin title 63
HPC and EC Culture Systems
###end title 63
###begin p 64
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 70 72 70 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 406 412 <span type="species:ncbi:9913">bovine</span>
In supernatant samples, CD34(+) hematopoietic progenitor cells (104-105 cells in 3 ml) were cultured in a 1:2 mixture of IL-1beta, IL-3 or IL-6 stimulated EC supernatant and stem cell medium in 6-well culture plates. Interleukin concentrations for endothelial stimulations ranged from 1 to 10,000 U/ml. Control samples consisted of non-stimulated supernatant and supernatant stimulated with 20 mul of 0.1% bovine serum albumin (1 mug/mL, Sigma-Aldrich) leading to a final concentration of 10 ng/ml. Other controls consisted of non-stimulated endothelial supernatant mixed with stem cell medium and supplemented with IL-1beta, IL-3 or IL-6 as well as a mix of endothelial and stem cell medium supplemented with interleukins. Cultures were fed once to twice a week by removal of 0.5 ml and replacement with 0.7 ml supernatant-media-mix.
###end p 64
###begin p 65
###xml 225 226 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 229 230 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
Cell counts, morphology, immune phenotype and colony formation were determined following a period of one and two weeks. Initial experiments included the comparison of direct contact and indirect contact systems. Here, HPC (104-105) were either cultured in direct contact with a confluent EC monolayer or on top of a 0.4 mum microporous transmembranes (Corning costar, ) above the EC layer. On five occasions, endothelial cells were replaced by bone marrow fibroblasts.
###end p 65
###begin title 66
Cell counts, morphology and flow cytometry
###end title 66
###begin p 67
After seven, fourteen and, for cumulative cell counts, after 21 days viable cells were determined by a hemocytometer using trypan blue. In direct contact cultures, HPC were distinguished from EC by assessing the number of CD45(+) cells by flow cytometry.
###end p 67
###begin p 68
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 263 265 263 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 348 353 <span type="species:ncbi:9606">human</span>
Frequencies of CD14, CD15, CD16, CD19, CD33, CD34, CD45, CD66 (all BD Pharmingen, San Diego, CA) and CD133 (PE-labeled, Miltenyi Biotech, Bergisch-Gladbach, Germany) positive cells were measured by dual staining as described previously [53]. Briefly, 0.5 - 1 x 105 cells were washed once with 1 ml PBS, and resuspended in 100 mul plus 1.8 mul anti-human FITC or PE labeled antibodies. After incubation for 20 minutes at 4degreesC, excess antibodies were removed and stained cells were analyzed by flow cytometry (FACScan, Becton Dickinson, Heidelberg, Germany).
###end p 68
###begin p 69
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
Light microscopy of cytospin preparations were carried out by Diffquik staining [54], and pictures were taken by a SC 35 Type 12 camera (Olympus, Hamburg, Germany) at 40x magnification.
###end p 69
###begin title 70
Hematopoietic colony formation
###end title 70
###begin p 71
###xml 73 75 73 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 492 494 492 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 209 213 <span type="species:ncbi:9913">calf</span>
The plating efficiency of the isolated HPC was analyzed by plating 1 x 103 CD34(+) hematopoietic progenitor cells in 1 ml of methylcellulose (Stem cell Technologies, Vancouver, BC) supplemented with 30% fetal calf serum, 20 ng/ml c-kit ligand (stem cell factor, Peprotech), 20 ng/ml IL-3, 6 U/ml erythropoietin (Roche, Hertfordshire, GB) and 100 ng/ml granulocyte-macrophage (GM) colony-stimulating factor (CSF, Peprotech) [52]. Input numbers of cultured cells were adjusted by multiplying 103 with the fold increases. After two weeks, cultures were scored for granulocyte-macrophage colony-forming units (CFU-GM), mixed colony forming units (CFU-Mix) and burst-forming units erythrocyte (BFU-E). Colonies consisting of more than 50 cells were scored using an inverted microscope and the plating efficiencies were determined by dividing the total number of colonies by the number of input cells. Each measurement was performed in triplicate.
###end p 71
###begin title 72
Cobblestone area-forming cells (CAFC) and long-term culture initiating cells (LTC-IC)
###end title 72
###begin p 73
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 193 195 193 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 310 313 306 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5 </sup>
###xml 152 158 <span type="species:ncbi:10090">murine</span>
###xml 246 251 <span type="species:ncbi:9796">horse</span>
CAFC assays were performed as previously described [55]. In brief, appropriate numbers of freshly isolated or expanded cells were seeded onto confluent murine bone marrow MS-5 stroma in 12.5-cm2 flasks in alpha-MEM medium supplemented with 12.5% horse serum (PAA Laboratories, Pasching, Germany), 12.5% FBS, 10-5 M hydrocortisone, 2 mM L-glutamine, 50 mug/ml gentamicin, and were demi-depopulated on a weekly basis. Cobblestone areas were scored at two and five weeks using an inverted phase microscope to identify phase-dark hematopoietic areas of at least five cells beneath the stromal layer. The LTC-IC content was determined by assaying for secondary colony forming cells in subsequent methylcellulose cultures following five weeks of stromal co-culture.
###end p 73
###begin title 74
Granulocytic differentiation
###end title 74
###begin p 75
###xml 151 153 151 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 450 452 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 244 249 <span type="species:ncbi:9606">human</span>
###xml 532 539 <span type="species:ncbi:562">E. coli</span>
For granulocytic maturation, two-week expanded cells were cultured for an additional week in IMDM supplemented with 20% FBS and 100 ng/ml G-CSF (4 x 105 cells in 2 ml). In some experiments, cells were kept at 37degreesC in autologous or pooled human serum prior to their functional assessment. Oxygen radical formation was determined using the commercially available Phagoburst test (Orpegen, Heidelberg, Germany) as recommended by the manufacturer [56]. Briefly, cultured cells were subjected to external stimuli such as opsonized E. coli, fMLP or PMA. Samples without any additional stimulus served as negative control. Dihydrorhodamine 123 (fluorescent rhodamine) indicated the presence of free oxygen radicals, which corresponded to NADPH oxidase activity. Cells were gated on granulocytes and their rhodamine fluorescence was measured by flow cytometry.
###end p 75
###begin title 76
Statistical analysis and ethics
###end title 76
###begin p 77
Student's t-tests for paired samples to compare results from interleukin- and non-treated or BSA-treated EC, calculation of means, standard errors and p-values were performed using Microsoft Excel 2000, Version 9.0. Differences with p-values less than 0.05 were termed as significant. The study was approved by the ethical review board of the Charite, registration number EA1/012/08.
###end p 77
###begin title 78
Authors' contributions
###end title 78
###begin p 79
AM designed the study, initiated the experiments, performed the statistical analysis and drafted the manuscript. GG carried out the cell cultures, flow cytometries, colony and cobblestone assays. GB performed the add-back experiments. AL performed granulocyte functional assays. HK conceived of the study and provided intellectual and financial support. AS conceived of the study, helped in the design and coordination and helped to draft the manuscript. All authors read and approved of the final version.
###end p 79
###begin title 80
Supplementary Material
###end title 80
###begin title 81
Additional file 1
###end title 81
###begin p 82
CD133 and CD34 expression of HPC cultured in IL-6 stimulated endothelial supernatant. after one week in culture (A) CD133 and CD34 were still present, whereas a distinct subset of CD133(+) cells did not stain for CD34. Reduced CD34 was paralleled by reduced CD133 positivity in the second week (B), while still more CD133(+)CD34(-) cells than double positive cells were detected.
###end p 82
###begin p 83
Click here for file
###end p 83
###begin title 84
Acknowledgements
###end title 84
###begin p 85
This study was supported by the Federal Ministry of Education and Research (Grant number 0311591). AM is currently sponsored by the Alexander-von Humboldt Foundation. We are indebted to the nurses and doctors, especially Jens Stupin and Gabriele Gossing of the obstetric department of the Charite for providing cord blood units and cords.
###end p 85
###begin article-title 86
Characterization of the adherence of normal and leukemic CD34+ cells to endothelial monolayers
###end article-title 86
###begin article-title 87
Lineage-specific hematopoietic growth factors
###end article-title 87
###begin article-title 88
Cell Migration and Inflammation
###end article-title 88
###begin article-title 89
Endothelial cell support of hematopoiesis is differentially altered by IL-1 and glucocorticoids
###end article-title 89
###begin article-title 90
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 92 97 <span type="species:ncbi:9606">human</span>
Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages
###end article-title 90
###begin article-title 91
###xml 81 86 <span type="species:ncbi:9606">human</span>
Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alpha
###end article-title 91
###begin article-title 92
###xml 62 67 <span type="species:ncbi:9606">human</span>
gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells
###end article-title 92
###begin article-title 93
###xml 142 147 <span type="species:ncbi:9606">human</span>
Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors
###end article-title 93
###begin article-title 94
IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes
###end article-title 94
###begin article-title 95
Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF)
###end article-title 95
###begin article-title 96
###xml 111 116 <span type="species:ncbi:9606">human</span>
Effects of interleukin-1, -2, -4, -6, interferon-gamma and granulocyte/macrophage colony stimulating factor on human vascular endothelial cells
###end article-title 96
###begin article-title 97
Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma
###end article-title 97
###begin article-title 98
Tumor necrosis factor alpha-stimulated endothelium: an inducer of dendritic cell development from hematopoietic progenitors and myeloid leukemic cells
###end article-title 98
###begin article-title 99
###xml 67 72 <span type="species:ncbi:9606">human</span>
Interleukin 1 stimulates endothelial cells to release multilineage human colony-stimulating activity
###end article-title 99
###begin article-title 100
###xml 52 57 <span type="species:ncbi:9606">human</span>
Cytokine-inducible growth factor gene expression in human umbilical endothelial cells
###end article-title 100
###begin article-title 101
###xml 25 30 <span type="species:ncbi:9606">human</span>
Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor
###end article-title 101
###begin article-title 102
Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF
###end article-title 102
###begin article-title 103
Cytokine and chemokine networks influencing stem cell proliferation, differentiation, and marrow homing
###end article-title 103
###begin article-title 104
###xml 58 63 <span type="species:ncbi:9606">human</span>
Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells
###end article-title 104
###begin article-title 105
###xml 15 20 <span type="species:ncbi:9606">human</span>
Stimulation of human endothelium with IL-3 induces selective basophil accumulation in vitro
###end article-title 105
###begin article-title 106
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human umbilical vein endothelial cells support interleukin-3- and interleukin-5-induced eosinophil differentiation from cord blood CD34+ cells
###end article-title 106
###begin article-title 107
Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors
###end article-title 107
###begin article-title 108
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 69 74 <span type="species:ncbi:9606">human</span>
Human umbilical vein endothelial cells increase ex vivo expansion of human CD34+ PBPC through IL-6 secretion
###end article-title 108
###begin article-title 109
Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities
###end article-title 109
###begin article-title 110
###xml 98 104 <span type="species:ncbi:10090">murine</span>
Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells
###end article-title 110
###begin article-title 111
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
###end article-title 111
###begin article-title 112
Expansion of cord blood CD34+ hematopoietic progenitor cells in coculture with autologous umbilical vein endothelial cells (HUVEC) is superior to cytokine-supplemented liquid culture
###end article-title 112
###begin article-title 113
Ex vivo expansion of haematopoietic progenitors on an endothelialized hydroxyapatite matrix
###end article-title 113
###begin article-title 114
Mesenchymal stem cells: properties and role in clinical bone marrow transplantation
###end article-title 114
###begin article-title 115
###xml 118 122 <span type="species:ncbi:10090">mice</span>
Transplantation of vascular endothelial cells mediates the hematopoietic recovery and survival of lethally irradiated mice
###end article-title 115
###begin article-title 116
Differential expression of the common beta and specific alpha chains of the receptors for GM-CSF, IL-3, and IL-5 in endothelial cells
###end article-title 116
###begin article-title 117
Recent developments in the cell biology of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: activities on endothelial cells
###end article-title 117
###begin article-title 118
###xml 99 104 <span type="species:ncbi:9606">human</span>
Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells
###end article-title 118
###begin article-title 119
Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide
###end article-title 119
###begin article-title 120
###xml 39 54 <span type="species:ncbi:666">Vibrio cholerae</span>
A cellular metalloproteinase activates Vibrio cholerae pro-cytolysin
###end article-title 120
###begin article-title 121
###xml 127 132 <span type="species:ncbi:9606">human</span>
Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layer
###end article-title 121
###begin article-title 122
A novel role for proliferin-2 in the ex vivo expansion of hematopoietic stem cells
###end article-title 122
###begin article-title 123
Cocultivation of umbilical cord blood cells with endothelial cells leads to extensive amplification of competent CD34+CD38- cells
###end article-title 123
###begin article-title 124
Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system
###end article-title 124
###begin article-title 125
Ex vivo expansion of umbilical cord blood
###end article-title 125
###begin article-title 126
###xml 119 124 <span type="species:ncbi:9606">human</span>
IL1-alpha and TNF alpha act synergistically to stimulate production of myeloid colony-stimulating factors by culturing human bone marrow stroma cells and cloned cell strains
###end article-title 126
###begin article-title 127
###xml 75 81 <span type="species:ncbi:10090">murine</span>
Long-term expansion of hematopoietic cells in CD34+ cells co-cultures with murine osteopetrotic stroma cells, OP-9, transfected with adenovirus expressing thrombopoietin
###end article-title 127
###begin article-title 128
###xml 129 133 <span type="species:ncbi:10090">mice</span>
Ex vivo culture rescues hematopoietic stem cells with long-term repopulating capacity following harvest from lethally irradiated mice
###end article-title 128
###begin article-title 129
Role of umbilical vein endothelial cells in hematopoiesis
###end article-title 129
###begin article-title 130
###xml 30 35 <span type="species:ncbi:9606">human</span>
Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation
###end article-title 130
###begin article-title 131
Characterization of the interactions between stromal and haematopoietic progenitor cells in expansion cell culture models
###end article-title 131
###begin article-title 132
###xml 17 22 <span type="species:ncbi:9606">human</span>
New immortalized human stromal cell lines enhancing in vitro expansion of cord blood hematopoietic stem cells
###end article-title 132
###begin article-title 133
###xml 111 116 <span type="species:ncbi:9606">human</span>
The type of stromal feeder used in limiting dilution assays influences frequency and maintenance assessment of human long-term culture initiating cells
###end article-title 133
###begin article-title 134
###xml 2 8 <span type="species:ncbi:10090">murine</span>
###xml 70 75 <span type="species:ncbi:9606">human</span>
A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38- progenitor cells in long-term cultures and semisolid assays
###end article-title 134
###begin article-title 135
###xml 40 46 <span type="species:ncbi:10090">murine</span>
Hematopoietic-promoting activity of the murine stromal cell line MS-5 is not related to the expression of the major hematopoietic cytokines
###end article-title 135
###begin article-title 136
Tumor Necrosis Factor Alpha Enhances the Adenoviral Transduction of CD34(+) Hematopoietic Progenitor Cells
###end article-title 136
###begin article-title 137
Optimized culture conditions for the generation of dendritic cells from peripheral blood monocytes
###end article-title 137
###begin article-title 138
Differences in the transmigration of different dendritic cells
###end article-title 138
###begin article-title 139
###xml 10 16 <span type="species:ncbi:9913">bovine</span>
Long-term bovine hematopoietic engraftment with clone-derived stem cells
###end article-title 139
###begin article-title 140
Flow cytometric measurement of the respiratory burst activity of phagocytes using dihydrorhodamine 123
###end article-title 140

